Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat + Fulvestrant in HR+/HER2- Advanced Breast Cancer Post-CDK4/6i
NCT07235618Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in breast cancer, sponsored by Sun Yat-sen University. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07235618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07235618.